Ertugliflozin pidolate is a pharmaceutical raw material used as an active ingredient in medications for type 2 diabetes. It is a salt form of ertugliflozin combined with pidolic acid, featuring a multi-ring structure with aromatic and heterocyclic components.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ertugliflozin pidolate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ertugliflozin
pharmaceutical raw material
Insulin Lispro
pharmaceutical raw material
MT-II
pharmaceutical raw material
SN38 glucuronide
pharmaceutical raw material
4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXYQUINOLIN-7-OL
pharmaceutical raw material
Cefprozil hydrate
pharmaceutical raw material
(1r,2s,3s,4r,5s)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyl triacetate
pharmaceutical intermediate
The international HS code for Ertugliflozin pidolate (CAS 1210344-83-4) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid
YHIUPZFKHZTLSH-LXYIGGQGSA-N
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl.C1CC(=O)N[C@@H]1C(=O)O
Sourcing Ertugliflozin pidolate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.